About: Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 1999

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 1999 (uk) im November 1999 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 01 November 1999 (en) artículu científicu espublizáu en payares de 1999 (ast)
publication date	wds:Q73154667-5533EA5C-9415-4DB8-8AE2-29A67623B81F
publication date	1999-11-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q73154667-54C34DE1-F02D-4C9E-9A85-08A9B29209B4 wds:Q73154667-70790C7F-3F01-4B15-870E-C167085AC907 wds:Q73154667-9FA2C540-89F0-4FB9-B555-4D8386B4D90A wds:Q73154667-BBBC8EA2-D872-4D8E-9BC5-EAF393761772 wds:Q73154667-F0083413-FC99-4F5F-B327-69FC5E00C009
author name string	J Bousquet P H Howarth R Reynolds M A Stern L Roi
rdfs:label	Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis (en) Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis (nl)
skos:prefLabel	Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis (en) Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis (nl)
name	Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis (en) Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis (nl)
title	wds:Q73154667-C678934E-5F1D-456B-8D49-C72F58583493
title	Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis (en)
page(s)	wds:Q73154667-A790C3DA-EF90-4CBA-A2FE-D5492AF74EB9
page(s)	927-933
instance of	wds:Q73154667-F8D28875-6EC4-43ED-91FE-C81105467C10
instance of	scholarly article
main subject	wds:Q73154667-0AED6AC4-057D-4315-8816-5D4F8B9B21D0 wds:Q73154667-1E7C7DDB-7509-439E-8F63-0740B6C1EABA wds:Q73154667-8C4E7B30-85D1-41E2-8DE4-BB05F80341C8
main subject	placebo allergic rhinitis seasonal allergic rhinitis
PubMed ID	wds:Q73154667-947F14A5-30DE-4BB8-B8BD-43F8724FFF0B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10550734
PubMed ID	10550734
published in	wds:Q73154667-DF7B38F7-1117-4C8B-891D-729C9B6B7A98
published in	The Journal of Allergy and Clinical Immunology
issue	wds:Q73154667-7C28757E-32EF-4048-A576-3A317EA8EF32
volume	wds:Q73154667-14AD2C96-C7DA-4CF6-934A-1620F46EC517
issue	5
volume	104
DOI	wds:Q73154667-05BFB3DB-0A42-401F-B0B4-EB37A9F0B59A
DOI	http://dx.doi.org/10.1016/S0091-6749(99)70070-9
DOI	10.1016/S0091-6749(99)70070-9
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73154667
is cites work of	Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis Pharmacology of antihistamines Loratadine versus cetirizine: assessment of somnolence and motivation during the workday A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects Comparative pharmacology of H1 antihistamines: clinical relevance Twenty-four hours of activity of cetirizine and fexofenadine in the skin Treatment of congestion in upper respiratory diseases Cetirizine: a review of its use in allergic disorders Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England. New insights into the second generation antihistamines Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis The efficacy of short-term administration of 3 antihistamines vs placebo under natural exposure to Japanese cedar pollen Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria BSACI guidelines for the management of allergic and non-allergic rhinitis Is the increasing use of evidence-based pharmacotherapy causing the renaissance of complementary medicine? Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis Pollen-specific immunoglobulin E positivity is associated with worsening of depression scores in bipolar disorder patients during high pollen season Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression Histamine and leukotriene receptor antagonism in the treatment of allergic rhinitis: an update Second-generation antihistamines: actions and efficacy in the management of allergic disorders H1-Antihistamines: more relevant than ever in the treatment of allergic disorders A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis Changes in allergy symptoms and depression scores are positively correlated in patients with recurrent mood disorders exposed to seasonal peaks in aeroallergens. A single-center, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol, with hydroxyzine hydrochloride 50 mg as a positive internal control, on aspects of cog Cost-effectiveness of second-generation antihistamines and montelukast in relieving allergic rhinitis nasal symptoms Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies Morning versus evening dosing of desloratadine in seasonal allergic rhinitis: a randomized controlled study [ISRCTN23032971 Selecting the optimal oral antihistamine for patients with allergic rhinitis Allergic inflammation in the unified airway: start with the nose Efficacy and safety profile of fexofenadine HCl: a unique therapeutic option in H1-receptor antagonist treatment Review of fexofenadine in the treatment of chronic idiopathic urticaria Pharmacology of antihistamines. Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria Experimental models for the evaluation of treatment of allergic rhinitis The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis The cost of treating allergic rhinitis Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis Intranasal corticosteroids for allergic rhinitis: superior relief? Efficacy of loratadine-montelukast on nasal congestion in patients with seasonal allergic rhinitis in an environmental exposure unit Once-daily immediate-release fexofenadine and sustained-release pseudoephedrine combination: a new treatment option for allergic rhinitis Similar rapid onset of action and magnitude of effect of fexofenadine and cetirizine as assessed by inhibition of histamine-induced wheal-and-flare reaction Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old. Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis Pharmacotherapy of allergic eye disease Effect of fexofenadine hydrochloride on cedar pollinosis Effects of inclusion of cetirizine hydrochloride in β-cyclodextrin

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software